Home / Generics

Generics

News

Indian generics makers begin to dispatch remdesivir posted 24/07/2020

Generic drugmakers Hetero and Cipla are among the first Indian manufacturers to dispatch a generic version of the investigati...

Generics of apixaban and chlorzoxazone approved in EU and US posted 03/07/2020

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended a generic version...

Aurobindo Pharma receives FDA approval for three generics posted 12/06/2020

India-based generics maker Aurobindo Pharma (Aurobindo) has received three approvals from the US Food and Drug Administration...

COVID-19 drugs: Gilead’s remdesivir and Algernon’s alternative posted 22/05/2020

Gilead Sciences has signed licensing agreements with five generics manufacturers based in India and Pakistan to increase prod...

FDA approves Proventil and Daraprim generics posted 12/05/2020

The US Food and Drug Administration (FDA) has approved the first generic version of a commonly used inhaler, marketed as Prov...

 

Research

Study reveals link between socioeconomic status and brand-name prescriptions posted 01/08/2020

A link between socioeconomic status and the prescription of brand-name drugs in the US, has been revealed by a team of resear...

Cost savings from the use of generic Gleevec (imatinib) posted 22/07/2020

Modelling of the cost savings from the use of generic Gleevec (imatinib) in the US finds that US payers saved US$2.5 billion...

Cost-effectiveness of generic dabigatran posted 16/07/2020

Since the enactment of Hatch-Waxman Act in 1984, use of generics has grown substantially in the US. Generics now account for...

Differences in originator and generic drug labels: impact on patient safety posted 26/06/2020

The labels for established generics and their originators differ. Especially when it comes to safety messaging, these differe...

Generics substitution in Finland: a pharmacy customer perspective posted 24/06/2020

Generics offer less expensive alternatives to brand-name drugs. However, they must be accepted by patients to increase uptake...

 

General

Generics applications under review by EMA – July 2020 posted 22/07/2020

Generic medicines in Europe can be approved either centrally via the European Medicines Agency (EMA) or nationally via the lo...

HIV drug Kaletra appears on Russian black market posted 22/07/2020

There are several reports of a black market in Russia emerging for the HIV drug Kaletra, following claims that it can be used...

CMS proposes new measures to rate generic usage posted 22/07/2020

The Centers for Medicare & Medicaid Services (CMS) is actively working to promote competition and lower costs for drugs,...

Science, outreach, development: US Generics Drugs Office reaches new highs in 2019 posted 22/07/2020

The US Food and Drug Administration (FDA) Office of Generic Drugs 2019 Annual report gave updates on the number of generics a...

Improving the pathway for generics approval in the US: 2019 update posted 22/07/2020

The US Food and Drug Administration’s (FDA) Office of Generic Drugs released their 2019 annual report in February 2020. This...